| AVRI | acute viral respiratory infection |
|---|---|
| BVD | bovine viral diarrhea |
| CVTR | charcoal viral transport medium |
| FVR | feline viral rhinotracheitis; forearm vascular resistance |
| PVS | percussion, vibration, suction; persistent vegetative state; persistent viral syndrome; Plummer-Vins... |
| haemophilus vaccines | Vaccines or candidate vaccines containing antigenic polysaccharides from haemophilus influenzae and designed to prevent infection. The vaccine can contain the polysaccharides alone or more frequently polysaccharides conjugated to carrier molecules. It is also seen as a combined vaccine with diphtheria-tetanus-pertussis vaccine. (12 Dec 1998) |
|---|---|
| saids vaccines | Vaccines or candidate vaccines designed to prevent saids (simian acquired immunodeficiency syndrome) and containing inactivated siv or type d retroviruses or some of their component antigens. (12 Dec 1998) |
| hepatitis b vaccines | Vaccines or candidate vaccines containing inactivated hepatitis b or some of its component antigens and designed to prevent hepatitis b. Some vaccines may be recombinantly produced. (12 Dec 1998) |
| protozoan vaccines | Suspensions of attenuated or killed protozoa administered for the prevention or treatment of infectious protozoan disease. (12 Dec 1998) |
| hog cholera vaccines | Vaccine's either of virus from blood of infected swine, inactivated with crystal violet, or live virus attenuated in rabbits or tissue culture and frequently used in conjunction with hog cholera virus antiserum. (05 Mar 2000) |
| influenza virus vaccines | Influenza virus grown in embryonated eggs and inactivated, usually by the addition of formalin; both whole virus and subunit preparations containing haemagglutinins and neuraminidase are used; because of the marked and progressive antigenic variation of the influenza viruses, the strains included are regularly changed following various outbreaks of influenza in order to include most recently isolated epidemic strains of both type A influenza and type B influenza. (05 Mar 2000) |
| foot-and-mouth disease virus vaccines | Vaccine's either of inactivated virus from infected cattle tongue epithelium or, more recently, of live virus attenuated by embryonated egg or mouse passage and propagated in tissue culture. (05 Mar 2000) |
| fungal vaccines | Suspensions of attenuated or killed fungi administered for the prevention or treatment of infectious fungal disease. (12 Dec 1998) |
| live vaccines | Vaccines containing living organisms or intact viruses. (14 Nov 1997) |
| acute viral conjunctivitis | An epidemic inflammation of the conjunctiva marked by follicles, especially in the lower fornix; may be caused by adenoviruses, herpesvirus, and Newcastle disease virus. (05 Mar 2000) |
| antibodies, viral | Immunoglobulins produced as a response to viral antigens; includes all classes of immunoglobulins elicited by all viral components. (12 Dec 1998) |
| antigens, viral | Substances elaborated by viruses that have antigenic activity. (12 Dec 1998) |
| antigens, viral, tumour | Those proteins recognised by antibodies from serum of animals bearing tumours induced by viruses; these proteins are presumably coded for by the nucleic acids of the same viruses that caused the neoplastic transformation. (12 Dec 1998) |
| avian viral arthritis virus | A virus of the genus Reovirus, family Reoviridae, causing tenosynovitis and arthritis in chickens. (05 Mar 2000) |
| bronchiolitis, viral | An acute inflammatory disease of the upper respiratory tract, caused by paramyxoviruses, occurring primarily in infants and young children; the viruses most commonly implicated are parainfluenza type 3 and respiratory syncytial virus. (12 Dec 1998) |